Boston Scientific’s first polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe more

1 Mar 2016 17:17 News

The Majestic clinical trial assessing Boston Scientific’s Eluvia drug-eluting vascular stent system reflected a primary patency rate of more than 96% more

27 Oct 2015 09:34 News